Delivery Order SPE2DR25D3012-SPE2DR26F4D7V
- Not listed
- The Defense Logistics Agency awarded a $1,237.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL pen format, with completion scheduled for November 10, 2025. This is a non-set-aside competitive award issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical vendor for federal medical procurement. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities, with a ceiling value of $1,967.64 and an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award...
- The Defense Logistics Agency awarded a delivery order valued at $1,980.00 to AmerisourceBergen Drug Corp for Lantus SoloStar insulin (100 units/mL, 3mL formulation) on December 18, 2025, with completion scheduled for December 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,403.24 for Lantus SoloStar 100 Unit/mL 3mL insulin on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $14,583.67 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL configurations. This firm fixed-price, competitively awarded delivery order is scheduled for completion by December 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3mL quantities, valued at $1,113.75. This competitively awarded, firm fixed-price delivery order was issued on October 23, 2025, with an ultimate completion date of October 24, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $1,323.98 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lantus SoloStar 100 Unit/ml 3ml insulin pens. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by December 2, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,551.96 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin on December 18, 2025, with completion scheduled for December 19, 2025. This delivery order is issued under a firm fixed-price arrangement with no set-aside designation, reflecting open competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,237.50 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on November 25, 2025, with an ultimate completion date of November 26, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $2,435.84 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin on September 23, 2025, with completion expected by September 24, 2025. This firm fixed-price contract represents a single delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4D7VDelivery Order
The Defense Logistics Agency awarded a $1,999.74 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL quantities. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 19, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that serves as the primary pharmaceutical supply vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare supplier that provides a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support Department of Defense and veteran healthcare needs. As the sole awardee on this delivery order, the company demonstrated its capability to meet federal procurement requirements through open competition. This insulin supply order represents a routine pharmaceutical procurement transaction within the broader scope of AmerisourceBergen's extensive federal contract portfolio, which encompasses diabetes medications, neurological treatments, pain management pharmaceuticals, and other medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/17/25 |